2025年3月最新中科院分区数据已更新,欢迎查询使用。如果您对期刊系统有任何需求或者问题,欢迎
反馈给我们。近期推荐: | 热 SCI论文AI润色+人工QC服务 | 热 赛默飞基础学科研究有奖问卷 | 热 同行专家帮助选刊 | 热 Springer Nature特刊征稿 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Drug Design Development and Therapy DRUG DES DEV THER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.0
74人评分
我要评分
声誉 7.4 影响力 6.1 速度 8.9 | |||||||||||||||||||||||||||||||
期刊ISSN | 1177-8881 | 微信扫码收藏此期刊 | ||||||||||||||||||||||||||||||
2023-2024最新影响因子 (数据来源于搜索引擎) | 4.7 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:5.143 | |||||||||||||||||||||||||||||||
2023-2024自引率 | 2.10%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 4.8 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.1 | |||||||||||||||||||||||||||||||
h-index | 48 | |||||||||||||||||||||||||||||||
CiteScore ( 2024年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | https://www.dovepress.com/drug-design-development-and-therapy-journal | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Drug Design Development and Therapy的语言要求,还能让Drug Design Development and Therapy编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Drug Design Development and Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢(2篇) 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:drug design、drug safety、drug development、pharmaecuticals 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||
通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||||||||||||
出版商 | Dove Medical Press Ltd. | |||||||||||||||||||||||||||||||
涉及的研究方向 | CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY | |||||||||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||||
出版年份 | 2007 | |||||||||||||||||||||||||||||||
年文章数 | 256点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 97.50% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 80.08% | |||||||||||||||||||||||||||||||
WOS期刊SCI分区 ( 2023-2024年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院SCI期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院SCI期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-8881%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: >12周,或约稿 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Drug Design Development and Therapy顺利发表。
快看看作者怎么说吧:服务好评(2篇) 论文致谢(2篇) 。 提交文稿 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Crop Wild Relatives (CWRs) in the United Arab Emirates: Resources for Climate Resilience and Their Potential Medicinal Applications Author: Manoharan, Ramya; Nair, Chythra Somanathan; Nishanth, Drishya; Subramanian, Radhakrishnan; Xie, Xiulan; Ren, Maozhi; Jaleel, Abdul Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 1515-1525. DOI: 10.2147/DDDT.S497800 PubMed DOI |
2. | An Open-Label, Single and Multiple Dose Study to Evaluate the Pharmacokinetics and Safety of Fezolinetant in Healthy Chinese Female Subjects Author: Li, Yang; Liu, Yue; Iwai, Megumi; Takeuchi, Masato; Song, Nan; Li, Yuan; Shi, Aixin Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2243-2252. DOI: 10.2147/DDDT.S486562 PubMed DOI |
3. | Global Research Status of Maca (Lepidium Meyenii Walp.): A Bibliometric Analysis of Hotspots, Bursts, and Trends Author: Li, Kangjie; Zhao, Chongbo; Dang, Ming; Ren, Runxin; Fu, Maomao; Bai, Yaya; Wang, Jing; Zhang, Qiao; Luan, Fei Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2329-2349. DOI: 10.2147/DDDT.S499849 PubMed DOI |
4. | Buyang Huanwu Decoction Alleviates Ischemic Stroke Injury by Inhibiting Ferroptosis via the Nrf2/GPX4 Pathway Author: Huang, Hao; Liu, Sijie; Wu, Jing; Zhu, Jiayi; Xu, Jiaxiang; Yu, Shuhong; Bei, Lingna; Zhang, Biao; Luo, Yi Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2285-2305. DOI: 10.2147/DDDT.S503424 PubMed DOI |
5. | S-Ketamine Reduces the Risk of Rebound Pain in Patients Following Total Knee Arthroplasty: A Randomized Controlled Trial Author: Li, Qun; Tian, Shaoqi; Zhang, Lei; Chai, Dongyue; Liu, Jia; Sheng, Fang; Jiang, Xin; Feng, Wei; Zhao, Yang; Zhu, Youzhuang Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2315-2327. DOI: 10.2147/DDDT.S515741 PubMed DOI |
6. | pH-Sensitive Porphyrin Metal-Organic Frameworks for Controlled Delivery of Para-Toluenesulfonamide and Photodynamic Cancer Therapy Author: Zhou, Wei; Feng, Fan; Zhang, Jieli; Cao, Shuang; Zhou, Yunzhi; Li, Yanming Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2351-2368. DOI: 10.2147/DDDT.S504891 PubMed DOI |
7. | Curcumin Analog J7 Attenuates Liver Fibrosis and Metabolic Dysregulation in a Rat Model of Type 2 Diabetes via Modulation of TGF-(3/Smad and NF-κB/ BCL-2/BAX Pathways Author: Ma, Jun; Chen, Wei; Vaishnani, Deep K.; Wang, Congying; Xue, Shuman; Yang, Qiuqin; Tong, Yuheng; Lei, Ningjia; Zhao, Zhichao; Ying, Furong Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2411-2432. DOI: 10.2147/DDDT.S511372 PubMed DOI |
8. | A Progesterone Microneedle Patch for Self-Administration in the Prevention of Preterm Birth in a Mouse Model Author: Yu, Hang; Zhu, Wenting; Yuan, Zhongwen; Feng, Senling; Huang, Hanhui; Yan, Pengke Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2473-2490. DOI: 10.2147/DDDT.S502701 PubMed DOI |
9. | Bibliometric and Visualization Analysis of DprE1 Inhibitors to Combat Tuberculosis Author: Wang, Qingqing; Fu, Huixiao; Zhang, Yining; Zhang, Man; Xu, Jian; Fu, Jian Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2577-2596. DOI: 10.2147/DDDT.S515049 PubMed DOI |
10. | Ginkgolide B Inhibits EMT and Promotes Pyroptosis in Gastric Cancer via AKT/mTOR Pathway Author: Lu, Xinxing; Zhang, Yan; Wang, Ran; Li, Ziyu Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 2491-2502. DOI: 10.2147/DDDT.S485240 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室